Key terms
About PRE
Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the prevention, early detection, and treatment of diseases. It operates through the Prevention and Diagnostic segments. The Prevention segment is involved in the design and sale of genetics testing and stool-based DNA tests for early colorectal cancer screening. The Diagnostic segment consists of COVID-19 testing services and products, and precision oncology services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PRE news
Apr 04
7:13am ET
Prenetics price target lowered to $9 from $10 at Cantor Fitzgerald
Apr 01
7:32am ET
Prenetics reports Q4 EPS ($1.57) vs 21c last year
Feb 09
9:28am ET
Prenetics enters MOU for investment, research collaboration with Metavisionaries
Jan 17
7:06am ET
Prenetics files to sell 1.48M Class A ordinary shares for holders
No recent press releases are available for PRE
PRE Financials
Key terms
Ad Feedback
PRE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PRE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
